Could high PSA (Prostate-specific Antigen) be prostate cancer?

High PSA levels can indicate prostate cancer but aren't definitive—infections, BPH, and other factors can also elevate PSA. Most men with elevated PSA don't have cancer, but levels above 4 ng/mL warrant further testing to rule out malignancy.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What Is PSA and Why Does It Matter?

Prostate-specific antigen (PSA) is a protein produced by cells in the prostate gland—both normal cells and cancer cells. When you get a PSA blood test, it measures the amount of this protein circulating in your bloodstream. While PSA testing has become a cornerstone of prostate health screening, understanding what your results mean requires more nuance than simply looking at a single number.

The prostate naturally releases small amounts of PSA into the blood, but various conditions can cause these levels to rise. This is why an elevated PSA doesn't automatically mean cancer—it's more like a check engine light that signals the need for further investigation. Regular PSA monitoring can help detect potential prostate issues early, when they're most treatable.

Understanding PSA Levels and Cancer Risk

PSA levels are measured in nanograms per milliliter (ng/mL) of blood. While there's no perfect cutoff that definitively separates cancer from non-cancer cases, medical professionals use established ranges to assess risk and guide next steps.

PSA Levels and Cancer Risk

Cancer risk percentages are approximate and vary based on age, race, and other factors.
PSA Level (ng/mL)Cancer RiskTypical Next StepsAdditional Considerations
0-2.50-2.5Very Low (<10%)Continue routine screeningIdeal range for men under 50
2.5-4.02.5-4.0Low (10-15%)Annual monitoringConsider free PSA if concerned
4.0-10.04.0-10.0Moderate (25%)Free PSA, possible MRI/biopsyMost common gray zone
Above 10>10High (>50%)Urgent urological referralBiopsy usually recommended

Cancer risk percentages are approximate and vary based on age, race, and other factors.

Age-Adjusted PSA Ranges

PSA levels naturally increase with age as the prostate grows larger. What's considered normal for a 70-year-old man would be concerning in someone who's 50. Age-specific ranges help provide more accurate risk assessment:

  • Men in their 40s: 0-2.5 ng/mL
  • Men in their 50s: 0-3.5 ng/mL
  • Men in their 60s: 0-4.5 ng/mL
  • Men 70 and older: 0-6.5 ng/mL

PSA Velocity and Doubling Time

Beyond absolute PSA levels, doctors also consider how quickly PSA rises over time. A rapid increase, even within the normal range, can be more concerning than a stable but slightly elevated level. PSA velocity (the rate of PSA increase per year) above 0.75 ng/mL annually may warrant closer monitoring or additional testing.

Non-Cancer Causes of Elevated PSA

Many men with elevated PSA levels don't have prostate cancer. In fact, only about 25% of men with PSA levels between 4-10 ng/mL are found to have cancer upon biopsy. Understanding other causes of PSA elevation can help reduce anxiety and guide appropriate follow-up.

Benign Prostatic Hyperplasia (BPH)

BPH, or enlarged prostate, is the most common cause of elevated PSA in older men. As the prostate grows larger with age, it produces more PSA. Men with BPH typically experience urinary symptoms like frequent urination, weak stream, or difficulty starting urination. Unlike cancer, BPH is not life-threatening, though it can significantly impact quality of life.

Prostatitis and Infections

Inflammation or infection of the prostate (prostatitis) can cause dramatic PSA elevations—sometimes 10 times higher than baseline. These spikes are usually temporary and return to normal after treatment with antibiotics. Urinary tract infections can also cause temporary PSA elevation.

Other Factors Affecting PSA

  • Recent ejaculation (can raise PSA for 24-48 hours)
  • Vigorous exercise, especially cycling
  • Digital rectal exam or prostate massage
  • Recent prostate biopsy or surgery
  • Certain medications (finasteride and dutasteride actually lower PSA)
  • Urinary catheter placement

When High PSA Suggests Cancer

While PSA alone can't diagnose cancer, certain patterns and levels are more concerning. PSA levels above 10 ng/mL carry a greater than 50% chance of cancer, while levels above 20 ng/mL are even more worrisome. However, some aggressive prostate cancers can occur with relatively low PSA levels, which is why additional factors matter.

The free PSA test can help clarify cancer risk. PSA exists in two forms in the blood: bound to proteins and free-floating. Men with prostate cancer tend to have less free PSA. A free PSA percentage below 10% suggests higher cancer risk, while above 25% indicates lower risk.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Next Steps After High PSA Results

If your PSA is elevated, don't panic. Your doctor will likely recommend a stepwise approach to determine the cause and appropriate treatment. The first step is often repeating the PSA test in 4-6 weeks, as levels can fluctuate. If PSA remains elevated, additional testing options include:

  • Free PSA test to calculate the free-to-total PSA ratio
  • PSA density calculation (PSA level divided by prostate volume)
  • 4Kscore or PHI (Prostate Health Index) blood tests
  • MRI of the prostate to identify suspicious areas
  • Prostate biopsy if cancer suspicion remains high

Modern prostate biopsies are typically performed using MRI fusion technology, which combines MRI images with real-time ultrasound to target suspicious areas more accurately. This approach reduces the risk of missing significant cancers while avoiding unnecessary biopsies of benign tissue.

PSA Screening Guidelines and Recommendations

Professional organizations have varying recommendations for PSA screening, reflecting the test's benefits and limitations. The American Urological Association recommends shared decision-making for men aged 55-69, while the U.S. Preventive Services Task Force suggests discussing potential benefits and harms with your doctor.

Men at higher risk may benefit from earlier or more frequent screening. Risk factors include:

  • African American race (2-3 times higher risk)
  • Family history of prostate cancer, especially in father or brother
  • Genetic mutations (BRCA1, BRCA2, Lynch syndrome)
  • Previous abnormal PSA results or prostate biopsy

Living with Elevated PSA

If you have elevated PSA but no cancer diagnosis, you'll likely enter an active surveillance protocol. This involves regular PSA testing (every 3-6 months), periodic digital rectal exams, and possibly repeat biopsies or MRIs. While this watchful waiting can cause anxiety, remember that most men with moderately elevated PSA never develop clinically significant prostate cancer.

Lifestyle modifications may help maintain prostate health and potentially lower PSA levels. These include maintaining a healthy weight, exercising regularly, eating a diet rich in vegetables and low in red meat, and managing stress. Some studies suggest that foods high in lycopene (tomatoes) and omega-3 fatty acids (fish) may support prostate health.

The Future of Prostate Cancer Detection

Research continues to improve prostate cancer detection beyond traditional PSA testing. New biomarkers like PCA3 and TMPRSS2:ERG fusion genes show promise for more specific cancer detection. Liquid biopsies that detect circulating tumor cells or DNA may eventually provide non-invasive ways to monitor cancer risk and progression.

Artificial intelligence is also being applied to prostate MRI interpretation and biopsy analysis, potentially improving accuracy and reducing the variability between different radiologists and pathologists. These advances aim to solve the fundamental challenge of PSA testing: distinguishing aggressive cancers that need treatment from slow-growing tumors that may never cause harm.

Making Informed Decisions About Your Prostate Health

High PSA levels can be concerning, but they're just one piece of the prostate health puzzle. Most men with elevated PSA don't have cancer, and even among those who do, many have slow-growing tumors that may never require treatment. The key is working with your healthcare provider to understand your individual risk factors, interpret your test results in context, and make informed decisions about further testing and monitoring.

Regular monitoring remains crucial for early detection when treatment is most effective. By understanding what PSA levels mean and what factors can influence them, you can approach prostate health screening with knowledge rather than fear, making decisions that align with your values and health goals.

References

  1. Catalona, W. J., Partin, A. W., Sanda, M. G., et al. (2011). A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. Journal of Urology, 185(5), 1650-1655.[PubMed][DOI]
  2. Thompson, I. M., Pauler, D. K., Goodman, P. J., et al. (2004). Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. New England Journal of Medicine, 350(22), 2239-2246.[PubMed][DOI]
  3. Loeb, S., Bjurlin, M. A., Nicholson, J., et al. (2014). Overdiagnosis and overtreatment of prostate cancer. European Urology, 65(6), 1046-1055.[PubMed][DOI]
  4. Carter, H. B., Albertsen, P. C., Barry, M. J., et al. (2013). Early detection of prostate cancer: AUA Guideline. Journal of Urology, 190(2), 419-426.[PubMed][DOI]
  5. Vickers, A. J., Brewster, S. F. (2012). PSA velocity and doubling time in diagnosis and prognosis of prostate cancer. British Journal of Medical and Surgical Urology, 5(4), 162-168.[DOI]
  6. Nordström, T., Akre, O., Aly, M., et al. (2018). Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer. Prostate Cancer and Prostatic Diseases, 21(1), 57-63.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my PSA at home?

You can test your PSA at home with SiPhox Health's Hormone Focus Program, which includes PSA testing for men along with other key hormone biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home.

What PSA level indicates prostate cancer?

There's no specific PSA level that definitively indicates cancer. While levels above 4 ng/mL are traditionally considered elevated, about 15% of men with PSA below 4 have cancer, and 75% with PSA between 4-10 don't have cancer. Your doctor will consider your age, PSA velocity, and other risk factors.

Can PSA levels go down naturally?

Yes, PSA levels can decrease naturally if the elevation was due to temporary factors like infection, inflammation, or recent sexual activity. Treating prostatitis with antibiotics, avoiding activities that irritate the prostate, and maintaining overall prostate health through diet and exercise may help lower PSA levels.

Should I avoid certain activities before a PSA test?

Yes, you should avoid ejaculation for 48 hours before testing, vigorous exercise (especially cycling) for 48 hours, and schedule the test before any digital rectal exam. These activities can temporarily elevate PSA and give false results.

At what age should men start PSA testing?

Most guidelines recommend discussing PSA screening with your doctor starting at age 50 for average-risk men. However, men at higher risk (African American men or those with family history) should consider starting at age 40-45. The decision should be individualized based on your risk factors and preferences.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details